RxDoctor Payments DataLook up a doctor →

Francine Martyn, PA

Medical · Scottsdale, AZNPI 1205302411

Payments from drug & device makers

$10,195in general payments, 2019–2025

Across 536 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$904
  • Dexcom, Inc.$734
  • Amgen$678
  • Novo Nordisk$631
  • Radius Health, Inc.$559
  • Sanofi-aventis U.S. LLC$527
  • plus $6K from 43 others

What the payments were for

  • Food & beverage$10,172100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,195 in reported general payments places this provider in the 90th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Medicare billing

Part B allowed, 2024
$1,938
Medicare patients
13
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide252$387,344
GenotropinSomatropin60$175,158
JardianceEmpagliflozin97$122,506
TrulicityDulaglutide95$120,917
MounjaroTirzepatide67$86,659
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog62$61,483
RybelsusSemaglutide30$48,625
Norditropin FlexproSomatropin11$44,890
Tresiba Flextouch U-200Insulin Degludec26$39,872
OmnitropeSomatropin14$32,581
JanuviaSitagliptin Phosphate18$30,498
ProliaDenosumab16$27,947
Tresiba Flextouch U-100Insulin Degludec44$27,505
Fiasp FlextouchInsulin Aspart (Niacinamide)32$24,748
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/714$21,796

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$631$447,267317 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro$904$217,659205 claims
Boehringer IngelheimJardiance$203$122,50697 claims
MerckJanuvia$14$30,49818 claims
AmgenProlia$678$27,94716 claims
AbbVieSynthroid, Armour Thyroid$385$21,605247 claims
Sanofi-aventis U.S. LLCAdmelog, Lantus$527$11,89229 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$495$8,897631 claims
IBSA Pharma Inc.Tirosint-Sol$22$2,03312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 748 medical providers in Arizona.

Other medical in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →